Figure 1. Mechanistic insights into the application of engineered bacterial-based in vivo drug delivery systems for disease therapy. (A) Intestinal in situ production of anti-inflammatory mediators; (B) Diabetes therapy in animal models; (C) Antitumor strategy; (D) Neurodegenerative disease intervention.
All published articles are preserved here permanently:
https://www.portico.org/publishers/oae/We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.
By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection. See our privacy policy for more information on the use of your personal data.
